Allogene Therapeutics, Inc.
All insider transactions
| Move | Insider | Δ shares | Value | Impact |
|---|---|---|---|---|
| Other | Kazam Joshua A Director | +47,700 | $0 | low |
| Sell | Beneski Benjamin Machinas Executive | -4,835 | $11.9K | low |
| Sell | David D. Chang, M.D., Ph.D. CEO | -47,763 | $118.0K | medium |
| Sell | Beneski Benjamin Machinas Executive | -7,132 | $18.5K | low |
| Sell | Yoshiyama Annie Executive | -4,167 | $7.2K | low |
| Sell | Beneski Benjamin Machinas Executive | -7,549 | $13.1K | low |
| Sell | David D. Chang, M.D., Ph.D. CEO | -95,269 | $171.5K | medium |
| Sell | Parker Geoffrey M. Executive | -24,001 | $42.2K | low |
| Sell | Roberts Zachary Executive | -35,700 | $63.2K | low |
| Sell | Douglas Earl Martin Executive | -22,900 | $40.3K | low |
| Sell | Roberts Zachary Executive | -26,269 | $41.0K | low |